Which drug class is the treatment of choice for depression in patients with cardiovascular disease?

Which drug class is the treatment of choice for depression in patients with cardiovascular disease?

• A. TCAs
• B. MAO inhibitors
• C. SSRIs
• D. SNRIs

Answer: (C)

The main concept is choosing an antidepressant with the safest cardiovascular profile. In patients with heart disease, we want effective relief of depressive symptoms without adding cardiac risk. SSRIs fit this well because they have minimal impact on cardiac conduction, blood pressure, and heart rate compared with older antidepressants. They avoid the strong anticholinergic and arrhythmia risks seen with tricyclics, and they don’t carry the dietary and hypertensive risks associated with MAO inhibitors. While SNRIs can be effective, they may increase blood pressure or heart rate in some patients, making them less ideal as a first choice in cardiovascular disease. Among SSRIs, sertraline is often preferred due to favorable safety data, though all SSRIs are generally safer in this setting than the other classes. Be mindful that some SSRIs carry QT prolongation risk at higher doses (for example, citalopram), so dosing matters. In short, the SSRI class is the best choice for depression in patients with cardiovascular disease because of its safer cardiovascular safety profile and tolerability.

The main concept is choosing an antidepressant with the safest cardiovascular profile. In patients with heart disease, we want effective relief of depressive symptoms without adding cardiac risk. SSRIs fit this well because they have minimal impact on cardiac conduction, blood pressure, and heart rate compared with older antidepressants. They avoid the strong anticholinergic and arrhythmia risks seen with tricyclics, and they don’t carry the dietary and hypertensive risks associated with MAO inhibitors. While SNRIs can be effective, they may increase blood pressure or heart rate in some patients, making them less ideal as a first choice in cardiovascular disease. Among SSRIs, sertraline is often preferred due to favorable safety data, though all SSRIs are generally safer in this setting than the other classes. Be mindful that some SSRIs carry QT prolongation risk at higher doses (for example, citalopram), so dosing matters. In short, the SSRI class is the best choice for depression in patients with cardiovascular disease because of its safer cardiovascular safety profile and tolerability.